Jag Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-15,674
| Closed | -$6.55M | – | 143 |
|
2024
Q1 | $6.55M | Sell |
15,674
-13,736
| -47% | -$5.74M | 0.93% | 34 |
|
2023
Q4 | $12M | Sell |
29,410
-12,776
| -30% | -$5.2M | 1.83% | 22 |
|
2023
Q3 | $14.7M | Sell |
42,186
-579
| -1% | -$201K | 1.77% | 20 |
|
2023
Q2 | $15M | Sell |
42,765
-698
| -2% | -$246K | 1.74% | 20 |
|
2023
Q1 | $13.7M | Sell |
43,463
-588
| -1% | -$185K | 1.77% | 19 |
|
2022
Q4 | $12.7M | Sell |
44,051
-2,037
| -4% | -$588K | 1.84% | 20 |
|
2022
Q3 | $13.3M | Buy |
46,088
+6,159
| +15% | +$1.78M | 1.86% | 17 |
|
2022
Q2 | $11.3M | Buy |
39,929
+36,199
| +970% | +$10.2M | 1.39% | 26 |
|
2022
Q1 | $802K | Buy |
+3,730
| New | +$802K | 0.08% | 122 |
|
2021
Q3 | – | Sell |
-3,730
| Closed | -$752K | – | 240 |
|
2021
Q2 | $752K | Hold |
3,730
| – | – | 0.06% | 137 |
|
2021
Q1 | $802K | Sell |
3,730
-4,215
| -53% | -$906K | 0.07% | 127 |
|
2020
Q4 | $1.88M | Sell |
7,945
-58,263
| -88% | -$13.8M | 0.17% | 85 |
|
2020
Q3 | $18M | Sell |
66,208
-625
| -0.9% | -$170K | 1.86% | 22 |
|
2020
Q2 | $19.4M | Buy |
66,833
+2,405
| +4% | +$698K | 2.27% | 16 |
|
2020
Q1 | $15.3M | Buy |
64,428
+39,654
| +160% | +$9.44M | 2.26% | 16 |
|
2019
Q4 | $5.42M | Buy |
+24,774
| New | +$5.42M | 0.62% | 40 |
|
2019
Q2 | – | Sell |
-53,003
| Closed | -$9.75M | – | 199 |
|
2019
Q1 | $9.75M | Buy |
53,003
+4,397
| +9% | +$809K | 1.59% | 29 |
|
2018
Q4 | $8.05M | Buy |
+48,606
| New | +$8.05M | 1.64% | 30 |
|
2018
Q3 | – | Sell |
-17,695
| Closed | -$3.01M | – | 105 |
|
2018
Q2 | $3.01M | Sell |
17,695
-43,560
| -71% | -$7.4M | 0.52% | 35 |
|
2018
Q1 | $9.98M | Buy |
+61,255
| New | +$9.98M | 1.85% | 27 |
|
2017
Q4 | – | Sell |
-33,583
| Closed | -$5.11M | – | 113 |
|
2017
Q3 | $5.11M | Buy |
+33,583
| New | +$5.11M | 0.96% | 36 |
|